Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for Postoperative Analgesia Following Pelvic Reconstructive Surgery
NCT07600697Phase 4Not yet recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Nov 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suzetrigine in postoperative pain, sponsored by University of California, Los Angeles. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07600697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07600697.